SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 124 600 KRW -0.72% Market Closed
Market Cap: 9.8T KRW

Intrinsic Value

The intrinsic value of one SK Biopharmaceuticals Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 124 600 KRW, SK Biopharmaceuticals Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

SK Biopharmaceuticals Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
SK Biopharmaceuticals Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

SK Biopharmaceuticals Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether SK Biopharmaceuticals Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about SK Biopharmaceuticals Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SK Biopharmaceuticals Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for SK Biopharmaceuticals Co Ltd.

Explain Valuation
Compare SK Biopharmaceuticals Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SK Biopharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
SK Biopharmaceuticals Co Ltd

Current Assets 576.1B
Cash & Short-Term Investments 222.6B
Receivables 198.8B
Other Current Assets 154.8B
Non-Current Assets 376.7B
Long-Term Investments 71.6B
PP&E 58.4B
Intangibles 29.3B
Other Non-Current Assets 217.4B
Current Liabilities 263.2B
Accounts Payable 2.5B
Accrued Liabilities 60.3B
Other Current Liabilities 200.3B
Non-Current Liabilities 94.4B
Long-Term Debt 42B
Other Non-Current Liabilities 52.4B
Efficiency

Free Cash Flow Analysis
SK Biopharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
SK Biopharmaceuticals Co Ltd

Revenue
620.3B KRW
Cost of Revenue
-42.8B KRW
Gross Profit
577.5B KRW
Operating Expenses
-429.9B KRW
Operating Income
147.6B KRW
Other Expenses
108.4B KRW
Net Income
256B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

SK Biopharmaceuticals Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional ROE
ROIC is Increasing
Exceptional Gross Margin
hidden
Profitability
Score

SK Biopharmaceuticals Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

SK Biopharmaceuticals Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

hidden
Solvency
Score

SK Biopharmaceuticals Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
SK Biopharmaceuticals Co Ltd

Wall Street analysts forecast SK Biopharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SK Biopharmaceuticals Co Ltd is 146 433.75 KRW with a low forecast of 71 710 KRW and a high forecast of 173 250 KRW.

Lowest
Price Target
71 710 KRW
42% Downside
Average
Price Target
146 433.75 KRW
18% Upside
Highest
Price Target
173 250 KRW
39% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

SK Biopharmaceuticals Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for SK Biopharmaceuticals Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one SK Biopharmaceuticals Co Ltd stock?

The intrinsic value of one SK Biopharmaceuticals Co Ltd stock under the Base Case scenario is hidden KRW.

Is SK Biopharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 124 600 KRW, SK Biopharmaceuticals Co Ltd is hidden .

Back to Top